NCT01985399View on ClinicalTrials.gov

"Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals (SHAC Neuro Study)"

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
HIVAIDS
Interventions
BEHAVIORAL

Neuropsychological testing

Neuropsychological testing

Trial Locations (1)

94304

Stanford University AIDS Clinical Trials Unit, Palo Alto

All Listed Sponsors
collaborator

Janssen Services, LLC

INDUSTRY

lead

Stanford University

OTHER

NCT01985399 - "Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals (SHAC Neuro Study)" | Biotech Hunter | Biotech Hunter